Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Current Leases (2023 - 2025)

Contineum Therapeutics (CTNM) has 3 years of Current Leases data on record, last reported at $1.5 million in Q3 2025.

  • For Q3 2025, Current Leases rose 141.73% year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, up 141.73%, while the annual FY2024 figure was $1.5 million, 212.93% up from the prior year.
  • Current Leases reached $1.5 million in Q3 2025 per CTNM's latest filing, up from $1.5 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.5 million in Q3 2025 and bottomed at $464000.0 in Q4 2023.
  • Average Current Leases over 3 years is $985375.0, with a median of $1.0 million recorded in 2024.
  • Peak YoY movement for Current Leases: soared 212.93% in 2024, then skyrocketed 141.73% in 2025.
  • A 3-year view of Current Leases shows it stood at $464000.0 in 2023, then skyrocketed by 212.93% to $1.5 million in 2024, then grew by 1.72% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $1.5 million in Q3 2025, $1.5 million in Q2 2025, and $1.5 million in Q1 2025.